These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32527027)

  • 41. Synthesis and comparative in vivo evaluation of
    Vats K; Satpati D; Sharma R; Sarma HD; Banerjee S
    Chem Biol Drug Des; 2017 Mar; 89(3):371-378. PubMed ID: 27561428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (99m)Tc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma-2 Receptor Ligands for Tumor Imaging.
    Li D; Chen Y; Wang X; Deuther-Conrad W; Chen X; Jia B; Dong C; Steinbach J; Brust P; Liu B; Jia H
    J Med Chem; 2016 Feb; 59(3):934-46. PubMed ID: 26741785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells.
    Jiménez-Mancilla N; Ferro-Flores G; Santos-Cuevas C; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Isaac-Olivé K; Camacho-López M; Torres-García E
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):663-71. PubMed ID: 25196028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin.
    Kunstler JU; Bergmann R; Gniazdowska E; Koźmiński P; Walther M; Pietzsch HJ
    J Inorg Biochem; 2011 Nov; 105(11):1383-90. PubMed ID: 21946438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
    Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H
    Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Rezazadeh F; Sadeghzadeh N; Abedi SM; Abediankenari S
    Nucl Med Biol; 2018; 62-63():54-62. PubMed ID: 29885559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preclinical Evaluation of
    Oroujeni M; Rinne SS; Vorobyeva A; Loftenius A; Feldwisch J; Jonasson P; Chernov V; Orlova A; Frejd FY; Tolmachev V
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
    Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (99m)Tc-labeling of ciprofloxacin and nitrofuryl thiosemicarbazone using fac-[(99m)Tc(CO)3(H2O)3] core: evaluation of their efficacy as infection imaging agents.
    Halder KK; Nayak DK; Baishya R; Sarkar BR; Sinha S; Ganguly S; Debnath MC
    Metallomics; 2011 Oct; 3(10):1041-8. PubMed ID: 21833405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
    Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of (99m)Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7-14) SPECT/CT in prostate cancer patients: a first-in-man study.
    Ananias HJ; Yu Z; Hoving HD; Rosati S; Dierckx RA; Wang F; Yan Y; Chen X; Pruim J; Lub-de Hooge MN; Helfrich W; Elsinga PH; de Jong IJ
    Nucl Med Biol; 2013 Oct; 40(7):933-8. PubMed ID: 23891351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and Development of
    Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
    J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood-brain barrier.
    Tournier N; André P; Blondeel S; Rizzo-Padoin N; du Moulinet d'Hardemarre A; Declèves X; Scherrmann JM; Cisternino S
    J Pharm Sci; 2009 Dec; 98(12):4650-60. PubMed ID: 19492342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer.
    Kasten BB; Ma X; Cheng K; Bu L; Slocumb WS; Hayes TR; Trabue S; Cheng Z; Benny PD
    Bioconjug Chem; 2016 Jan; 27(1):130-42. PubMed ID: 26603218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.
    García Garayoa E; Schweinsberg C; Maes V; Rüegg D; Blanc A; Bläuenstein P; Tourwé DA; Beck-Sickinger AG; Schubiger PA
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):42-50. PubMed ID: 17372572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
    Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of New
    Şenışık AM; İçhedef Ç; Kılçar AY; Uçar E; Arı K; Parlak Y; Bilgin ES; Teksöz S
    Anticancer Agents Med Chem; 2019; 19(11):1382-1387. PubMed ID: 30947676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melanoma targeting with [
    Carta D; Salvarese N; Morellato N; Gao F; Sihver W; Pietzsch HJ; Biondi B; Ruzza P; Refosco F; Carpanese D; Rosato A; Bolzati C
    Nucl Med Biol; 2016 Dec; 43(12):788-801. PubMed ID: 27694057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Kannan R; Volkert WA; Hoffman TJ
    Cancer Res; 2003 Jul; 63(14):4082-8. PubMed ID: 12874010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NOTA and NODAGA [
    Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
    Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.